The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

被引：424

作者：

Cookson, Mark R. ^{[1
]}

机构：

[1] NIA, Neurogenet Lab, NIH, Bethesda, MD 20982 USA

来源：

NATURE REVIEWS NEUROSCIENCE | 2010年 / 11卷 / 12期

基金：

美国国家卫生研究院;

关键词：

AUTOSOMAL-DOMINANT PARKINSONISM; ALPHA-SYNUCLEIN; LEUCINE-RICH-REPEAT-KINASE-2; LRRK2; CYTOPLASMIC LOCALIZATION; 14-3-3; BINDING; ROC DOMAIN; MUTATIONS; PROTEIN; PHOSPHORYLATION; GENE;

D O I：

10.1038/nrn2935

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Parkinson's disease, like many common age-related conditions, is now recognized to have a substantial genetic component. Here, I discuss how mutations in a large complex gene-leucine-rich repeat kinase 2 (LRRK2) - affect protein function, and I review recent evidence that LRRK2 mutations affect pathways that involve other proteins that have been implicated in Parkinson's disease, specifically a-synuclein and tau. These concepts can be used to understand disease processes and to develop therapeutic opportunities for the treatment of Parkinson's disease.

引用

页码：791 / 797

页数：7

共 74 条

[11] Inhibition of LRRK2 kinase activity leads to dephosphorylation of Ser910/Ser935, disruption of 14-3-3 binding and altered cytoplasmic localization
Dzamko, Nicolas
Deak, Maria
Hentati, Faycal
Reith, Alastair D.
Prescott, Alan R.
Alessi, Dario R.
Nichols, R. Jeremy
[J]. BIOCHEMICAL JOURNAL, 2010, 430 : 405 - 413
[12] An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
Funayama, M
Hasegawa, K
Ohta, E
Kawashima, N
Komiyama, M
Kowa, H
Tsuji, S
Obata, F
[J]. ANNALS OF NEUROLOGY, 2005, 57 (06) : 918 - 921
[13] A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
Funayama, M
Hasegawa, K
Kowa, H
Saito, M
Tsuji, S
Obata, F
[J]. ANNALS OF NEUROLOGY, 2002, 51 (03) : 296 - 301
[14] LRRK2 expression linked to dopamine-innervated areas
Galter, D
Westerlund, M
Carmine, A
Lindqvist, E
Sydow, O
Olson, L
[J]. ANNALS OF NEUROLOGY, 2006, 59 (04) : 714 - 719
[15] The Roc domain of leucine-rich repeat kinase 2 is sufficient for interaction with microtubules
Gandhi, Payal N.
Wang, Xinglong
Zhu, Xiongwei
Chen, Shu. G.
Wilson-Delfosse, Amy L.
[J]. JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (08) : 1711 - 1720
[16] Molecular pathogenesis of Parkinson disease: insights from genetic studies
Gasser, Thomas
[J]. EXPERT REVIEWS IN MOLECULAR MEDICINE, 2009, 11
[17] Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression
Gehrke, Stephan
Imai, Yuzuru
Sokol, Nicholas
Lu, Bingwei
[J]. NATURE, 2010, 466 (7306) : 637 - U9
[18] Common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, WP
Abou-Sleiman, PM
Gandhi, S
Jain, S
Singleton, A
Lees, AJ
Shaw, K
Bhatia, KP
Bonifati, V
Quinn, NP
Lynch, J
Healy, DG
Holton, JL
Revesz, T
Wood, NW
[J]. LANCET, 2005, 365 (9457) : 415 - 416
[19] Leucine-rich repeat kinase 2 phosphorylates brain tubulin-beta isoforms and modulates microtubule stability - a point of convergence in Parkinsonian neurodegeneration?
Gillardon, Frank
[J]. JOURNAL OF NEUROCHEMISTRY, 2009, 110 (05) : 1514 - 1522
[20] Phosphopeptide Analysis Reveals Two Discrete Clusters of Phosphorylation in the N-Terminus and the Roc Domain of the Parkinson-Disease Associated Protein Kinase LRRK2
Gloeckner, Christian Johannes
Boldt, Karsten
von Zweydorf, Felix
Helm, Sandra
Wiesent, Ludwig
Sarioglu, Hakan
Ueffing, Marius
[J]. JOURNAL OF PROTEOME RESEARCH, 2010, 9 (04) : 1738 - 1745

← 1 2 3 4 5 6 7 8 →